MIT Biotechnology Group

BMS Golden Ticket Lab Space Competition

Bristol-Myers Squibb is now accepting applications for its 2017 Golden Ticket Program for one year of underwritten lab space at LabCentral!

The Program will award a total of two Golden Tickets to the one or two companies that best meet the judging criteria of the Program, including that they are engaged in therapeutic research in the fields of Oncology, Immunology, Cardiovascular, or Fibrosisand/or are companies pursuing research in novel target identification, drug delivery, discovery technology platforms, or translational R&D.
Applications for the Program are accepted June 26 – July 21, 2017Applicants selected to be finalists will be notified by Bristol-Myers Squibb on or prior to August 31.  Awardees will be announced following the innovation showcase on or around September 19. By applying, Applicants agree to the Official Rules.

Leave a Reply